Sarah Gheuens is Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO). They have made 2 open-market trades across 1 company since 2023, most recently 2026-08-04.
CIK 0001881190
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGIO | 54,645 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGIO | SELL · 10b5-1 | 2026-08-04 | 2026-08-06 | $30.48 | $914K | +7.0% | +4.4% | — |
| AGIO | SELL · 10b5-1 | 2026-07-01 | 2026-07-02 | $37.56 | $151K | +6.2% | -18.7% | -11.4% |
| AGIO | SELL · 10b5-1 | 2026-04-02 | 2026-04-06 | $34.71 | $102K | +0.3% | -22.5% | +7.5% |
| AGIO | SELL | 2026-03-02 | 2026-03-03 | $28.96 | $83K | -2.9% | +22.8% | -2.3% |
| AGIO | SELL · 10b5-1 | 2025-12-30 | 2026-01-02 | $27.09 | $79K | +5.7% | +3.6% | +29.6% |
| AGIO | SELL · 10b5-1 | 2025-11-11 | 2025-11-13 | $43.78 | $215K | -32.1% | -35.9% | -33.9% |
| AGIO | SELL · 10b5-1 | 2025-10-30 | 2025-11-03 | $43.81 | $9K | +8.2% | -30.1% | -28.4% |
| AGIO | SELL · 10b5-1 | 2025-10-27 | 2025-10-29 | $43.92 | $290K | -1.9% | -30.8% | -32.0% |
| AGIO | SELL · 10b5-1 | 2025-07-09 | 2025-07-11 | $37.96 | $872K | +5.6% | -8.7% | +10.5% |
| AGIO | SELL · 10b5-1 | 2025-07-01 | 2025-07-03 | $34.17 | $280K | +11.7% | +1.0% | +12.0% |
| AGIO | SELL · 10b5-1 | 2025-06-24 | 2025-06-26 | $33.54 | $195K | +16.1% | +10.5% | +10.9% |
| AGIO | SELL · 10b5-1 | 2025-03-03 | 2025-03-04 | $35.54 | $202K | -7.8% | -17.4% | -2.7% |
| AGIO | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $43.85 | $325K | +14.4% | +4.6% | +1.1% |
| AGIO | SELL · 10b5-1 | 2024-03-05 | 2024-03-05 | $32.57 | $86K | -4.6% | -11.1% | +39.6% |
| AGIO | SELL · 10b5-1 | 2024-02-14 | 2024-02-14 | $25.14 | $16K | +39.6% | +20.1% | +36.9% |
| AGIO | SELL · 10b5-1 | 2024-01-24 | 2024-01-24 | $21.64 | $37K | +9.0% | +51.5% | +46.1% |
| AGIO | SELL · 10b5-1 | 2024-01-09 | 2024-01-09 | $22.99 | $41K | -9.9% | +0.8% | +15.5% |
| AGIO | SELL | 2023-06-30 | 2023-06-30 | $28.36 | $48K | -0.6% | -5.7% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.